Bivalent recombinant human papillomavirus vaccine

N/A

Report date: 2024/07/03 21:31:43

Base Information

Drug NameBivalent recombinant human papillomavirus vaccine
Drug Alias Name二价重组人乳头瘤病毒疫苗HPV-2 vaccineRecombinant human papillomavirus bivalent (types 16 and 18) vaccine
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesShanghai Zerun Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Zerun Biotechnology Co Ltd
Active IndicationsN/A
Inactive IndicationsPapillomavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A